Literature DB >> 1691763

Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. II. Synthetic Pre-S(2) immunogen.

D R Milich1, J E Jones, A McLachlan, G Bitter, A Moriarty, J L Hughes.   

Abstract

One purpose of this study was to examine the influence of viral subtype on in vivo antibody production to the pre-S(2) region of the hepatitis B surface Ag. Immunization with hepatitis B surface Ag particles containing the pre-S(2) region of the d or y subtypes identified the B10.M (H-2f) strain as an antibody nonresponder to the pre-S(2) and S regions after immunization with the y subtype, but as an antibody responder to the pre-S(2) and S regions after immunization with the d subtype. Both the S region and pre-S(2) region-specific antibody responses emanated from pre-S(2)/d-specific Th cell function because B10.M mice are T cell nonresponsive to the S region of both subtypes. Although responder/nonresponder status of the B10.M strain was dependent on the pre-S(2) subtype used for immunization, the anti-pre-S(2) antibody produced was totally cross-reactive on both subtypes. This is consistent with the conserved nature of the dominant pre-S(2) antibody-binding site and the highly polymorphic nature of the pre-S(2) sequence that represents the focus of T cell recognition. These data suggest that, to fully benefit from the inclusion of pre-S(2) region sequences, third generation hepatitis B virus vaccines should contain both the d and y subtype sequences of the pre-S(2) region to increase the frequency of pre-S(2) and S-specific antibody responses and to insure Th cell memory relevant to both viral subtypes. A second purpose of this study was to "design" a synthetic pre-S(2) immunogen based on combining the dominant B and T cell recognition sites into a single peptide. A composite peptide consisting of the dominant T cell recognition sequence p151-174 positioned N-terminal to the dominant B cell site p133-143 (i.e., p151-174(133-143] yielded an effective pre-S(2) synthetic immunogen. Interestingly, the orientation of the T and B cell determinants and the context of the T cell site within the larger composite peptide influenced both antibody fine specificity and T cell fine specificity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691763

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopes.

Authors:  J H Mathews; J T Roehrig; J R Brubaker; A R Hunt; J E Allan
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Neutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees.

Authors:  Pei Zhang; Mei-Ying W Yu; Richard Venable; Harvey J Alter; J Wai-Kou Shih
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

3.  Expression and purification of the complete PreS region of hepatitis B Virus.

Authors:  Qiang Deng; Yu-Ying Kong; You-Hua Xie; Yuan Wang
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

4.  The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.

Authors:  F Schödel; A M Moriarty; D L Peterson; J A Zheng; J L Hughes; H Will; D J Leturcq; J S McGee; D R Milich
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

5.  Cloning and expression of the gene for the Avi-3 antigen of Mycobacterium avium and mapping of its epitopes.

Authors:  R Yamaguchi; K Matsuo; A Yamazaki; M Takahashi; Y Fukasawa; M Wada; C Abe
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.

Authors:  M McCarthy; A Lovett; R H Kerman; A Overstreet; J S Wolinsky
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

7.  Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma.

Authors:  Zhi Yong Gao; Tong Li; Jia Wang; Ji Mei Du; Ya Juan Li; Jie Li; Feng Min Lu; Hui Zhuang
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 6.772

8.  PreS1 epitope recognition in newborns after vaccination with the third-generation Sci-B-Vac vaccine and their relation to the antibody response to hepatitis B surface antigen.

Authors:  Ulla B Hellström; Kazimierz Madalinski; Staffan Pe Sylvan
Journal:  Virol J       Date:  2009-01-20       Impact factor: 4.099

9.  Naturally occurring hepatitis B virus B-cell and T-cell epitope mutants in hepatitis B vaccinated children.

Authors:  Yu-Min Lin; Guey-Mei Jow; Shu-Chi Mu; Bing-Fang Chen
Journal:  ScientificWorldJournal       Date:  2013-11-26

10.  Different pre-S deletion patterns and their association with hepatitis B virus genotypes.

Authors:  Bing-Fang Chen
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.